Kuano

Cambridge-based spin-out using quantum simulation and quantum-inspired AI to design enzyme inhibitors and novel small-molecule drugs. Its Quantum Lens platform applies physics-based quantum fingerprints to guide hit generation and compound optimisation for drug discovery programmes.